Treatment with insulin was required for all patients with confirmed Type 1 diabetes mellitus and insulin therapy was continued long …

required for evaluation and diagnosis of patients treated with Tecentriq as well as the monitoring required for adverse events and …

Treatment with insulin was required for all patients with confirmed Type 1 diabetes mellitus and insulin therapy was continued long …

Because of the specialized skills required for evaluation and diagnosis of patients treated with Tecentriq as well as the monitoring …

Information for healthcare professionals about the safety, efficacy, dosing, prescribing information and mechanism of action for …

TECENTRIQ, in combination with lurbinectedin, is indicated for the maintenance treatment of adult patients with ES-SCLC whose …

Because atezolizumab (Tecentriq®) enhances your immune system response to cancer, it may cause unintended side effects that …

Tecentriq Hybreza, in combination with paclitaxel protein-bound and carboplatin, is indicated for the first-line treatment of adult …

Jun 1, 2026 · Use of TECENTRIQ for this indication is supported by evidence from an adequate and well controlled study of …

Sep 10, 2023 · IMpower133 is a Phase III, multicentre, double-blinded, randomised placebo-controlled study evaluating the efficacy …